NASDAQ: LGND · Health Care / Biotechnology: Pharmaceutical Preparations

Ligand Pharmaceuticals Incorporated

How Ligand Pharmaceuticals Incorporated compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$6.3B

Price

$317.33

P/E

123.3

EPS (TTM)

$2.57

1-year return

72.0%

Dividend yield

0.0%

52-week range

$199.03–$317.33

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources